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1. INTRODUCTION {#joa312345-sec-0001}
===============

We reported in 2016 on cardiac implantable electrical device (CIED) infection rate in Japan and it showed an overall infection rate of 1.12%.[^1^](#joa312345-bib-0001){ref-type="ref"} The report was based on the interviews of the device implanters across Japan. Adding to that report, we seek cost effective and repetitive approach utilizing the Internet platform to access the CIED implanters across Japan. The infection and device migration are significant adverse effects for the CIED patients but not many evidences are available for Japanese patient population and medical environment. The significance of the event affects patients' mobility and mortality, length of hospitalization, and healthcare cost.[^2^](#joa312345-bib-0002){ref-type="ref"}, [^3^](#joa312345-bib-0003){ref-type="ref"}, [^4^](#joa312345-bib-0004){ref-type="ref"} Additionally, the status of application of prophylactic strategies in Japan where various antibiotic prophylactic regimens and surgical practice were mentioned in various consensus statements,[^5^](#joa312345-bib-0005){ref-type="ref"}, [^6^](#joa312345-bib-0006){ref-type="ref"} is not clear. Thus, adding another data on CIED infection and device migration in Japan would be valuable to those who perform CIED implants.

2. METHOD {#joa312345-sec-0002}
=========

A physician panel of Macromill Carenet Inc which consisted of more than six thousand cardiologists was utilized and the target panel was narrowed to CIED implanters and asked questions on CIED infection and migration. The web‐based questions were asked in a way such as "Please let us know how many cases you experienced device infection in recent one year?" and "For the infected patients what was the treatment? Please select from below with number of patients." In general, the questions were formulated in order to know the experience of the respondents, but not each case\'s clinical detail. The definition of the infection was: "The case which patient feels hot sensation, redness, and pain, and needed administration of antibacterial agent or prolongation of it, and/or needed surgical intervention such as re‐implantation." The definition of migration was: "The cases where device system was affected such as damage or dislodgement of the lead, and/or patient needed medical treatment. The questionnaire was open for two days for the panel. A total of 232 doctors answered to it, and 77 were excluded because they were not implanting CIEDs. A total of 155 answers were included in this report. The questions were asked such a way as "in your institute...", and it was confirmed that all the respondents were from different institute therefore representing unique individual hospital in this report.

3. RESULTS {#joa312345-sec-0003}
==========

Results are shown in Tables [1](#joa312345-tbl-0001){ref-type="table"}, [2](#joa312345-tbl-0002){ref-type="table"}, [3](#joa312345-tbl-0003){ref-type="table"}, [4](#joa312345-tbl-0004){ref-type="table"}, [5](#joa312345-tbl-0005){ref-type="table"}, [6](#joa312345-tbl-0006){ref-type="table"}, [7](#joa312345-tbl-0007){ref-type="table"}, [8](#joa312345-tbl-0008){ref-type="table"}. Tables [1](#joa312345-tbl-0001){ref-type="table"}and[2](#joa312345-tbl-0002){ref-type="table"} summarized the characteristics of institution which respondents were from. Most of the respondents belonged in Cardiology department and half of them performed all the CIED implant and the half performed PM implants only. Majority (65%) of institutes were medium‐ to large‐sized hospitals according to number of beds. The implant was mostly (79%) performed at Cath. Lab, and experience years of implanting physicians was relatively long (more than 10 years: 53%). The geographical coverage was wide (91.3% of all prefectures) and among 46 prefectures, four prefectures, for example, Fukushima, Nara, Shimane, and Okinawa were not covered. The most concentrated area was Tokyo and the ratio was 10.3%. The Implants were mostly (79%) performed at cath. Lab., and experience years of implanting physicians was relatively long (more than 10 years: 53%). Infection and device migration rate are shown in Table [3](#joa312345-tbl-0003){ref-type="table"}. Infection was categorized into "definitive" and "in‐definitive" because oftentimes it is difficult to reach to the definitive diagnosis.[^7^](#joa312345-bib-0007){ref-type="ref"} In this circumstance, the infection rate including in‐definitive ones was reported. The overall infection rate including in‐definitive diagnosis was 2.0%. As a reference, Table [3](#joa312345-tbl-0003){ref-type="table"} includes infection rate from recent report from Olsen et al[^8^](#joa312345-bib-0008){ref-type="ref"} from Danish device‐cohort. Table [4](#joa312345-tbl-0004){ref-type="table"} shows preventive measures prior or during implant procedure and administering direct and/or indirect antibiotics were main method followed by pocket cleansing. As the treatment of infection, invasive interventions were taken in 60% and it is significant event for the patients. Among various medical aspects of infection and migration, this is the first report in Japan which showed days of hospitalization and days to device replacement after device infection was diagnosed and is presented in Table [6](#joa312345-tbl-0006){ref-type="table"}. This suggested that when infection has occurred, significant hospital stay was needed and therefore suggesting healthcare burden may increase. Tables [7](#joa312345-tbl-0007){ref-type="table"}and[8](#joa312345-tbl-0008){ref-type="table"} show device migration consequences and its treatment. The major consequence of device migration is lead dislodgement (51%) and invasive treatment was needed in 39% of cases.

###### 

Institution of respondents (155 sites)

  Clinical department       Implanting CIED at institute   Number of beds                                 
  ------------------------- ------------------------------ ------------------------- ---------- --------- ----------
  Cardiology 134            (86.5%)                        All CIEDs                 80 (51%)   20‐99     7 (5%)
  Cardiac surgery           1(0.6%)                        PM only (\<20 annually)   29 (19%)   100‐199   24 (15%)
  Cardio vascular surgery   20 (12.9%)                     PM only (≧20 annually)    46 (30%)   200‐299   23 (15%)
                                                                                                300‐399   38 (24%)
                                                                                                400‐499   18 (12%)
                                                                                                ≧500      45 (29%)

Abbreviation: CIED, cardiac implantable electrical device.

John Wiley & Sons, Ltd

###### 

Characteristics of implants (155 sites)

  Number of implants   Implant facility   Experience years of implanter (n = 763)                      
  -------------------- ------------------ ----------------------------------------- ----------- ------ -----------
  PM initial           5348               Cath. lab.                                122 (79%)   \>3    122 (16%)
  PM replacement       2779               Operating room                            33 (21%)    3‐10   237 (31%)
  ICD initial          832                                                                      \>10   404 (53%)
  ICD replacement      402                                                                              
  CRT‐P initial        310                                                                              
  CRT‐P replacement    133                                                                              
  CRT‐D initial        463                                                                              
  CRT‐D replacement    182                                                                              

Abbreviation: CRT‐D, cardiac resynchronization therapy ICD; CRT‐P, cardiac resynchronization therapy pacemaker; ICD, implantable cardioverter defibrillator.

John Wiley & Sons, Ltd

###### 

Infection and device migration (155 sites) and reference from Danish Device‐Cohort

  CIED type                                     Number of implants   Infection (definitive)   Infection (incl. suspicious cases)   Device migration
  --------------------------------------------- -------------------- ------------------------ ------------------------------------ ------------------
  PM                                            8127                 64 (0.79％)              158 (1.9%)                           56 (0.68%)
  ICD                                           1234                 10 (0.81％)              25 (2.0%)                            8 (0.64%)
  CRT‐P                                         443                  2 (0.45％)               8 (1.8%)                             2 (0.45%)
  CRT‐D                                         645                  13 (2.0%)                27 (4.2%)                            6 (0.93%)
  Total                                         10 499               89 (0.85%)               218 (2.0%)                           72 (0.68%)
  Reference: Danish Device‐Cohort (1982‐2018)                                                                                      
  PM                                            100 374              1194 (1.19%)             ---                                  ---
  ICD                                           16 718               320 (1.91%)              ---                                  ---
  CRT‐P                                         4630                 101 (2.18%)              ---                                  ---
  CRT‐D                                         6323                 212 (3.35%)              ---                                  ---
  Total                                         128 045              1827 (1.43%)             ---                                  ---

Abbreviation: CIED, cardiac implantable electrical device; CRT‐P, cardiac resynchronization therapy pacemaker; CRT‐D, cardiac resynchronization therapy ICD; ICD, implantable cardioverter defibrillator.

John Wiley & Sons, Ltd

###### 

Prevention of infection (155 sites, multiple responses)

  Preventive measures for infection                 
  ------------------------------------------------- -----------
  Indirect antibiotics administration               122 (79%)
  Cleansing the pocket                              117 (75%)
  Subcutaneous implant                              54 (35%)
  Direct antibiotics administration in the pocket   46 (65%)
  Preoperative checking such as MRSA                38 (25%)
  Use of medical adhesive                           12 (8%)
  Use of antibacterial tape                         10 (6%)
  Other                                             3 (2%)

John Wiley & Sons, Ltd

###### 

Treatment of infection (Data from available 218 cases)

  Treatment                                              
  ------------------------------------------------------ ----------
  Administration/prolongation of antibiotics treatment   85 (39%)
  Entire system removal (device and leads)               65 (30%)
  Device removal                                         46 (21%)
  Reoperation for modification                           20 (9%)
  Other                                                  2 (1%)

John Wiley & Sons, Ltd

###### 

Duration of hospitalization and number of days to device replacement due to infection (Data from available 95 cases)

  CIED type   Hospitalization days                                 Days to device replacement
  ----------- ---------------------------------------------------- ------------------------------------------
  All         Average: 26.2 days (Min = 3, Max = 100, SD = 16.1)   20.5 days (Min = 1. Max = 80, SD = 14.2)

Abbreviation: CIED, cardiac implantable electrical device.

John Wiley & Sons, Ltd

###### 

Complication by device migration (data from available 69 cases)

  CIED type   Lead dislodgement   Twiddler\'s syndrome   No complication
  ----------- ------------------- ---------------------- -----------------
  All         35 (51%)            3 (4%)                 31 (45%)

Abbreviation: CIED, cardiac implantable electrical device.

John Wiley & Sons, Ltd

###### 

Treatment of device migration (data from available 72 cases)

  Treatment                                  
  ------------------------------------------ ----------
  Continuous observation                     23 (32%)
  Device removal                             19 (26%)
  Device reprograming                        16 (22%)
  Entire system removal (device and leads)   9 (13%)
  Other                                      5 (7%)

John Wiley & Sons, Ltd

4. CONCLUSION {#joa312345-sec-0004}
=============

The current status of infection, device migration, prophylactic measures, and post incident treatments among CIED patients were reported. Adding to that, utility of web‐based survey for real world medical environment in Japan was shown. The data presented in this report were snapshots of current medical practice and may not be suitable for further analysis for scientific conclusion, however, it may serve as one of the basic data of device infection and migration in Japan. Limitation of this report is that since the respondents were voluntarily answered according to their experience, personal bias may be introduced in the results.
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